Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
|---|---|---|---|---|---|---|---|---|---|
Patent 10238705 was granted and assigned to CURE Pharmaceutical on March, 2019 by the United States Patent and Trademark Office. | 10238705 | March 26, 2019 | |||||||
Patent 8999372 was granted and assigned to CURE Pharmaceutical on April, 2015 by the United States Patent and Trademark Office. | 8999372 | April 7, 2015 | |||||||
Patent 10092611 was granted and assigned to CURE Pharmaceutical on October, 2018 by the United States Patent and Trademark Office. | 10092611 | October 9, 2018 | |||||||
Patent 9155698 was granted and assigned to CURE Pharmaceutical on October, 2015 by the United States Patent and Trademark Office. | 9155698 | October 13, 2015 | |||||||
Patent 11160292 was granted and assigned to CURE Pharmaceutical on November, 2021 by the United States Patent and Trademark Office. | 11160292 | November 2, 2021 | |||||||
8840919 | September 23, 2014 | ||||||||
Patent 10413516 was granted and assigned to CURE Pharmaceutical on September, 2019 by the United States Patent and Trademark Office. | 10413516 | September 17, 2019 | |||||||
Patent 10398644 was granted and assigned to CURE Pharmaceutical on September, 2019 by the United States Patent and Trademark Office. | 10398644 | September 3, 2019 | |||||||
Patent 10470478 was granted and assigned to CURE Pharmaceutical on November, 2019 by the United States Patent and Trademark Office. | 10470478 | November 12, 2019 | |||||||
Patent 9561182 was granted and assigned to CURE Pharmaceutical on February, 2017 by the United States Patent and Trademark Office. | 9561182 | February 7, 2017 | |||||||
10624940 | April 21, 2020 | ||||||||
10639339 | May 5, 2020 |